CODX Co-Diagnostics Inc: Nilai Akuntansi saben Saham

The potential of Co-Diagnostics, Inc. (CODX) is based on the automation of PCR assays, which eliminates manual labor. The book value per common share clearly demonstrates asset dynamics, with the value stabilizing at 2.60. However, sales are constrained by US and Chinese trade barriers, while falling demand for tests forces the company to compete aggressively for market share against major players.

Co-Diagnostics Inc (CODX) - Nilai Akuntansi saben Saham saka 04.07.2022 nganti 27.10.2026

Ringkesan rincian data analitis codiagnostics.com (CODX)

- rega lan prakiraan konsensus rega:

Rega saham Co-Diagnostics Corp|CODX - Prakiraan gabungan firma investasi

- data kapitalisasi pasar:

Biji pasar Co-Diagnostics, Inc.|CODX - Nilai Bisnis

- data kapitalisasi buku:

Aset Bersih saben Siji Saham Co-Diagnostics|CODX - Aset Bersih Perusahaan|Rasio Kapitalisasi Pasar marang Nilai Buku codiagnostics.com|CODX - Aset Perusahaan

- data utang lan likuiditas:

Total Utang marang Modal Co-Diagnostics, Inc.|CODX - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal Co-Diagnostics|CODX - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku Co-Diagnostics, Inc.

Pambiji fundamental perusahaan:Co-Diagnostics, Inc.

To objectively assess the stability of Co-Diagnostics, Inc. (CODX), it is critical for a portfolio manager to calculate the net asset value per share, which measures the real value of the business's tangible assets and reserves. By analyzing the trend of the book value per share, an investor can track the accumulation of resources, which in this case is supported by the localization of production in the US and the optimization of reagent logistics to minimize external shocks.

Pesaing Co-Diagnostics, Inc. (CODX)